Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Zopiclone products are in shortage in Canada (6 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 27, 2026.
A sleep medication used for the short-term treatment of insomnia.
Products affected
6 / 24
In shortage since
Jun 20, 2017
Est. full return
Oct 27, 2026
Reports on file
52
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-ZOPICLONE
7.5MG · TABLET · APOTEX INC
DIN 02218313 · since Jul 7, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP ZOPICLONE
3.75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02549271 · since Jun 30, 2026, est. end Oct 27, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ZOPICLONE
7.5MG · TABLET · TEVA CANADA LIMITED
DIN 02242481 · since Dec 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MAR-ZOPICLONE
3.75MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02468115 · since Apr 20, 2020, no end estimate · Business reasons
Active shortage
SEPTA-ZOPICLONE
5MG · TABLET · SEPTA PHARMACEUTICALS INC
DIN 02386909 · since Jun 20, 2017, no end estimate
Active shortage
SEPTA-ZOPICLONE
7.5MG · TABLET · SEPTA PHARMACEUTICALS INC
DIN 02386917 · since Jun 20, 2017, no end estimate
Resolved
APO-ZOPICLONE
7.5MG · TABLET · APOTEX INC
DIN 02218313 · ended Sep 5, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ZOPICLONE
7.5MG · TABLET · APOTEX INC
DIN 02218313 · ended Aug 29, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-ZOPICLONE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02246534 · ended Jun 6, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ZOPICLONE
7.5MG · TABLET · APOTEX INC
DIN 02218313 · ended Feb 22, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ZOPICLONE
5MG · TABLET · APOTEX INC
DIN 02245077 · ended Feb 22, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ZOPICLONE
7.5MG · TABLET · APOTEX INC
DIN 02218313 · ended Nov 23, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 52 reports. All reports are on file with Health Canada.
What's happening
Zopiclone is currently affected by 6 active shortage reports filed with Health Canada by APOTEX INC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, MARCAN PHARMACEUTICALS INC and 1 others.
The reported causes are: disruption of the manufacture of the drug; business reasons. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Zopiclone is classified under “HYPNOTICS AND SEDATIVES” (ATC N05CF).
Recent changes
Jul 23, 2026
Estimated end date pushed back : Jul 24, 2026 → Jul 31, 2026
Jul 9, 2026
New report filed
Common questions
What is Zopiclone used for?
A sleep medication used for the short-term treatment of insomnia.
When will Zopiclone be back in stock in Canada?
The latest manufacturer estimate is Oct 27, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Zopiclone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.